Michael Lindner

Michael Lindner

Auto-generated profile, based on publicly available information

Michael Lindner

Asklepios Fachkliniken München-Gauting

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2015 in Nature
Verified
Journal Article
Open access
PDF file
JGJulie George
Julie George
JLJing Shan Lim
Jing Shan Lim
SJSe Jin Jang
Se Jin Jang
YCYupeng Cun
Yupeng Cun
LOLuka Ozretić
Luka Ozretić
RTRoman K. Thomas
Roman K. Thomas
We have sequenced the genomes of 110 small cell lung cancers (SCLC), one of the deadliest human cancers. In nearly all the tumours analysed we found bi-allelic inactivation of TP53 and RB1, sometimes by complex genomic rearrangements. Two tumours with wild-type RB1 had evidence of chromothripsis leading to overexpression of cyclin D1 (encoded by the CCND1 gene), revealing an alternative mechanism of Rb1 deregulation. Thus, loss of the tumour suppressors TP53 and RB1 is obligatory in SCLC. We discovered somatic genomic rearrangements of TP73 that create an oncogenic version of this gene, TP73Δex2/3. In rare cases, SCLC tumours exhibited kinase gene mutations, providing a possible therapeutic opportunity for individual patients. Finally, we observed inactivating mutations in NOTCH family genes in 25% of human SCLC. Accordingly, activation of Notch signalling in a pre-clinical SCLC mouse model strikingly reduced the number of tumours and extended the survival of the mutant mice. Furthermore, neuroendocrine gene expression was abrogated by Notch activity in SCLC cells. This first comprehensive study of somatic genome alterations in SCLC uncovers several key biological processes and identifies candidate therapeutic targets in this highly lethal form of cancer.

22 February 2015 in ACS Nano
Verified
Journal Article
Closed access
Sabine van RijtSabine van Rijt
Sabine van Rijt
DBDeniz Ali Bölükbas
Deniz Ali Bölükbas
CAChristian Argyo
Christian Argyo
SDStefan Datz
Stefan Datz
MLMichael Lindner
Michael Lindner
SMSilke Meiners
Silke Meiners

30 April 2015 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
FUFRANZISKA Elisabeth Uhl
FRANZISKA Elisabeth Uhl
SVSarah Vierkotten
Sarah Vierkotten
DWDarcy E. Wagner
Darcy E. Wagner
GBGerald Burgstaller
Gerald Burgstaller
RCRita Costa
Rita Costa
MKMelanie Königshoff
Melanie Königshoff
Chronic obstructive pulmonary disease (COPD) is characterised by a progressive loss of lung tissue. Inducing repair processes within the adult diseased lung is of major interest and Wnt/β-catenin signalling represents a promising target for lung repair. However, the translation of novel therapeutic targets from model systems into clinical use remains a major challenge.We generated murine and patient-derived three-dimensional (3D)ex vivolung tissue cultures (LTCs), which closely mimic the 3D lung microenvironmentin vivo.Using two well-known glycogen synthase kinase-3β inhibitors, lithium chloride (LiCl) and CHIR 99021 (CT), we determined Wnt/β-catenin-driven lung repair processes in high spatiotemporal resolution using quantitative PCR, Western blotting, ELISA, (immuno)histological assessment, and four-dimensional confocal live tissue imaging.Viable 3D-LTCs exhibited preserved lung structure and function for up to 5 days. We demonstrate successful Wnt/β-catenin signal activation in murine and patient-derived 3D-LTCs from COPD patients. Wnt/β-catenin signalling led to increased alveolar epithelial cell marker expression, decreased matrix metalloproteinase-12 expression, as well as altered macrophage activity and elastin remodelling. Importantly, induction of surfactant protein C significantly correlated with disease stage (per cent predicted forced expiratory volume in 1 s) in patient-derived 3D-LTCs.Patient-derived 3D-LTCs represent a valuable tool to analyse potential targets and drugs for lung repair. Enhanced Wnt/β-catenin signalling attenuated pathological features of patient-derived COPD 3D-LTCs.

15 August 2015 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
Claudia A. Staab-WeijnitzClaudia A. Staab-Weijnitz
Claudia A. Staab-Weijnitz
IFIsis E. Fernandez
Isis E. Fernandez
LKLarissa Knüppel
Larissa Knüppel
JMJulia Maul
Julia Maul
KHKatharina Heinzelmann
Katharina Heinzelmann
OEOliver Eickelberg
Oliver Eickelberg
Rationale: Increased abundance and stiffness of the extracellular matrix, in particular collagens, is a hallmark of idiopathic pulmonary fibrosis (IPF). FK506-binding protein 10 (FKBP10) is a collagen chaperone, mutations of which have been indicated in the reduction of extracellular matrix stiffness (e.g., in osteogenesis imperfecta). Objectives: To assess the expression and function of FKBP10 in IPF. Methods: We assessed FKBP10 expression in bleomycin-induced lung fibrosis (using quantitative reverse transcriptase–polymerase chain reaction, Western blot, and immunofluorescence), analyzed microarray data from 99 patients with IPF and 43 control subjects from a U.S. cohort, and performed Western blot analysis from 6 patients with IPF and 5 control subjects from a German cohort. Subcellular localization of FKBP10 was assessed by immunofluorescent stainings. The expression and function of FKBP10, as well as its regulation by endoplasmic reticulum stress or transforming growth factor-β1, was analyzed by small interfering RNA–mediated loss-of-function experiments, quantitative reverse transcriptase–polymerase chain reaction, Western blot, and quantification of secreted collagens in the lung and in primary human lung fibroblasts (phLF). Effects on collagen secretion were compared with those of the drugs nintedanib and pirfenidone, recently approved for IPF. Measurements and Main Results: FKBP10 expression was up-regulated in bleomycin-induced lung fibrosis and IPF. Immunofluorescent stainings demonstrated localization to interstitial (myo)fibroblasts and CD68+ macrophages. Transforming growth factor-β1, but not endoplasmic reticulum stress, induced FKBP10 expression in phLF. The small interfering RNA–mediated knockdown of FKBP10 attenuated expression of profibrotic mediators and effectors, including collagens I and V and α-smooth muscle actin, on the transcript and protein level. Importantly, loss of FKBP10 expression significantly suppressed collagen secretion by phLF. Conclusions: FKBP10 might be a novel drug target for IPF.

7 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OBOlga Bermudez
Olga Bermudez
EHElisabeth Hennen
Elisabeth Hennen
IKIna Koch
Ina Koch
MLMichael Lindner
Michael Lindner
OEOliver Eickelberg
Oliver Eickelberg
Non-Small-Cell-Lung-Cancer (NSCLC) represents approximately 85% of all lung cancers and remains poorly understood. While signaling pathways operative during organ development, including Sonic Hedgehog (Shh) and associated Gli transcription factors (Gli1-3), have recently been found to be reactivated in NSCLC, their functional role remains unclear. Here, we hypothesized that Shh/Gli1-3 could mediate NSCLC autonomous proliferation and epithelial/stromal signaling in the tumoral tissue. In this context, we have investigated the activity of Shh/Gli1-3 signaling in NSCLC in both, cancer and stromal cells. We report here that inhibition of Shh signaling induces a significant decrease in the proliferation of NSCLC cells. This effect is mediated by Gli1 and Gli2, but not Gli3, through regulation of cyclin D1 and cyclin D2 expression. While exogenous Shh was unable to induce signaling in either A549 lung adenocarcinoma or H520 lung squamous carcinoma cells, both cells were found to secrete Shh ligand, which induced fibroblast proliferation, survival, migration, invasion, and collagen synthesis. Furthermore, Shh secreted by NSCLC mediates the production of proangiogenic and metastatic factors in lung fibroblasts. Our results thus provide evidence that Shh plays an important role in mediating epithelial/mesenchymal crosstalk in NSCLC. While autonomous Gli activity controls NSCLC proliferation, increased Shh expression by NSCLC is associated with fibroblast activation in tumor-associated stroma. Our study highlights the relevance of studying stromal-associated cells in the context of NSCLC regarding new prognosis and therapeutic options.

5 February 2016 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
ASAnita I. R. Spanjer
Anita I. R. Spanjer
HBHoeke A. Baarsma
Hoeke A. Baarsma
LOLisette M. Oostenbrink
Lisette M. Oostenbrink
SJSepp R. Jansen
Sepp R. Jansen
CKChristine C. Kuipers
Christine C. Kuipers
MKMelanie Königshoff
Melanie Königshoff
TGF‐β is important in lung injury and remodeling processes. TGF‐β and Wingless/integrase‐1 (WNT) signaling are interconnected; however, the WNT ligand‐receptor complexes involved are unknown. Thus, we aimed to identify Frizzled (FZD) receptors that mediate TGF‐β‐induced profibrotic signaling. MRC‐5 and primary human lung fibroblasts were stimulated with TGF‐β 1 , WNT‐5A, or WNT‐5B in the presence and absence of specific pathway inhibitors. Specific small interfering RNA was used to knock down FZD8. In vivo studies using bleomycin‐induced lung fibrosis were performed in wild‐type and FZD8‐deficient mice. TGF‐β 1 induced FZD8 specifically via Smad3‐dependent signaling in MRC‐5 and primary human lung fibroblasts. It is noteworthy that FZD8 knockdown reduced TGF‐β 1 ‐induced collagen Iα1, fibronectin, versican, α‐smooth muscle (sm)‐actin, and connective tissue growth factor. Moreover, bleomycin‐induced lung fibrosis was attenuated in FZD8 ‐deficient mice in vivo. Although inhibition of canonical WNT signaling did not affect TGF‐β 1‐induced gene expression in vitro , noncanonical WNT‐5B mimicked TGF‐β 1 ‐induced fibroblast activation. FZD8 knockdown reduced both WNT‐5B‐induced gene expression of fibronectin and α‐sm‐actin, as well as WNT‐5B‐induced changes in cellular impedance. Collectively, our findings demonstrate a role for FZD8 in TGF‐β‐induced profibrotic signaling and imply that WNT‐5B may be the ligand for FZD8 in these responses.—Spanjer, A. I. R., Baarsma, H. A., Oostenbrink, L. M., Jansen, S. R., Kuipers, C. C., Lindner, M., Postma, D. S., Meurs, H., Heijink, I. H., Gosens, R., Königshoff, M. TGF‐β‐induced profibrotic signaling is regulated in part by the WNT receptor Frizzled‐8. FASEB J. 30, 1823–1835 (2016). www.fasebj.org